AI Science Tracker
EN

National Yang Ming Chiao Tung University

2 discoveries from 2023 to 2024

Discoveries

Personalized prediction of immunotherapy response in lung cancer patients using advanced radiomics and deep learning

Source check: Source checked. Not independent scientific confirmation.

Finding: Radiomic survival prediction in 206 immunotherapy patients reports improved progression-free survival discrimination and patient-group separation. This record is limited to the study result and does not establish independent replication or real-world benefit.

Technology: Radiomics machine-learning model

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Methods specify the AI/learned analysis that enabled the case-specific result: Radiomic survival prediction in 206 immunotherapy patients reports improved progression-free survival discrimination and patient-group separation.
Test and result
Radiomic survival prediction in 206 immunotherapy patients reports improved progression-free survival discrimination and patient-group separation.
Limitation / still unknown
No prospective clinical benefit or broader external validity is established by the documented study.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC11440728/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Upper-Arm Photoplethysmographic Sensor with One-Time Calibration for Long-Term Blood Pressure Monitoring

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: Pretrained expGPR is fine-tuned on upper-arm PPG; Methods describes calibration and reference BP comparison. Results compares estimated BP to reference readings in the 30 analyzed participants; limited sample and protocol-specific.

Technology: GPR

Publication: Publication status unspecified in annotation · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Pretrained expGPR is fine-tuned on upper-arm PPG; Methods describes calibration and reference BP comparison.
Limitation / still unknown
Publication status could not be established from the reviewed primary bibliographic metadata.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://europepmc.org/articles/PMC10046397 · https://pubmed.ncbi.nlm.nih.gov/36979533/

The legacy label “Not reported” does not distinguish information absent from reviewed material from information not assessed. It is not a scientific finding of absence.

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.